Browse Items (2 total)

• Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

  Tags Nipah (NiV), R-Res&Pub, R-T&C, Remdesivir
  Creator: Michael K. Lo, Friederike Feldmann, Joy M. Gary, Robert Jordan, Roy Bannister, Jacqueline Cronin, Nishi R. Patel, John D. Klena, Stuart T. Nichol, Tomas Cihlar, Sherif R. Zaki, Heinz Feldmann, Christina F. Spiropoulou, and Emmie de Wit.
  Subject: Laboratory
  Item Type: Publication
  Date Last Updated: 2019-05-29
  Description: Nipah virus is an emerging pathogen in the Paramyxoviridae family. Upon transmission of Nipah virus from its natural reservoir, Pteropus spp. fruit bats, to humans, it causes respiratory and neurological disease with a case-fatality rate about 70%.
• 

  Remdesivir for the Treatment of Covid-19 — Preliminary Report

  Tags 2019-nCoV, Clinical Trial, Coronavirus, COVID-19, R-Res&Pub, R-T&C, Remdesivir, Therapeutics
  Creator: the ACTT-1 Study Group Members
  Subject: Treatment & Care
  Item Type: Publication
  Date Last Updated: 2020-05-22
  Description: Discussing "a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement."